Cork University Hospital (CUH) is the largest National Cancer Control Programme (NCCP) designated cancer centre in the South of Ireland and a European Society for Medical Oncology (ESMO) designated centre for integrated oncology and palliative care. It is also a member of the Organisation of European Cancer Institutes (OECI). The provision of high-quality care for patients at risk of and with a diagnosis of cancer, as well as integration with innovative education and research initiatives, is central to its mission.
Core clinical facilities include inpatient, outpatient and chemotherapy day ward services as well as a state-of-the-art Radiation Oncology Cancer Centre in the Glandore Centre at CUH; one of the largest single site Radiation Oncology facilities in Ireland.
CUH houses a robust cancer clinical trials unit (Cancer Trials Cork) and the Clinical Research Facility-UCC to ensure access to novel diagnostics and therapies for patients with cancer. The broad portfolio encompasses phase I-III therapeutic trials in haematologic/solid malignancies, radiation therapy and surgery; including academic collaborative trials via Cancer Trials Ireland and industry trials, with a developing portfolio of UCC sponsored investigator-initiated trials led by our oncologists.